Agimexpharm Pharmaceutical Joint Stock Company
Agimexpharm Pharmaceutical Joint Stock Company
🇻🇳 Vietnam, An Giang
1981201-300 peopleManufacturer/DistributorAgimexpharm Pharmaceutical Joint Stock Company is a prominent Vietnamese pharmaceutical manufacturer and distributor headquartered in Long Xuyen, An Giang. Established in 1981 as the An Giang Pharmaceutical Factory and equitized in 2004, the company has over 40 years of industry experience. It operates advanced manufacturing facilities equipped with technology from the USA, France, Japan, and India, maintaining a workforce of approximately 200 to 500 employees. The company is publicly listed on the Hanoi Upcom Securities Trading Center under the symbol AGP.
Specializing in a broad spectrum of healthcare solutions, Agimexpharm produces chemical and herbal medicines, health supplements, cosmetics, and active pharmaceutical ingredients (APIs). Its diverse product portfolio includes prescription and generic drugs, vaccines, biologicals, and functional foods. Beyond core pharmaceuticals, the company manufactures medical equipment, PET plastic bottles, and PE packaging materials. Agimexpharm also provides comprehensive OEM and contract manufacturing services for the pharmaceutical sector.
Quality and compliance are central to the company's operations, evidenced by certifications including WHO-GMP, EU-GLP, and FDA specifications. The company utilizes a GSP-compliant warehouse system and advanced analytical equipment for rigorous quality control. With a strong domestic distribution network and growing international trade capabilities, Agimexpharm continues to expand its footprint in the global healthcare market, reporting steady financial growth and an annual revenue exceeding $20 million.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Own brandOwns and operates its own brands and manufacturing facilities.
High-tech enterpriseRecognized as a high-tech or innovative enterprise.
Established brandFounded in 1981, with over 20 years of industry experience.
Contact
*************
1
Products
BenBen
ESORAGIM 40
Sitagibes 100
AGIROVASTIN 20
AGIFUROS
Agi-Bromhexine 4
Customers
ALLA AAMIN PHARMACEUTICAL
*************
*********
********************
**********
Unlock all 12 customers
Certifications
GMP2
FDA2
Ask AI about this supplier
Key export market
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Imexpharm Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
19771001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
27
Key customer
BURYAT OMBOL
Key market
Europe
Description
Imexpharm Pharmaceutical Joint Stock Company is a premier Vietnamese pharmaceutical manufacturer and distributor with over 48 years of industry experience. Headquartered in Cao Lanh, the company operates four major manufacturing clusters across Dong Thap, Ho Chi Minh City, and Binh Duong. Imexpharm is a leader in high-tech pharmaceutical production, maintaining 11 production lines that meet stringent EU-GMP standards, alongside WHO-GMP, GMP-ASEAN, and ISO 9001:2015 certifications. The company employs between 1,001 and 2,000 professionals and maintains a robust distribution network of 20 sales branches nationwide.
Specializing in both the Ethical (ETC) and Over-the-Counter (OTC) channels, Imexpharm is the leading domestic brand in the Vietnamese antibiotics market. Its extensive product portfolio includes Penicillins, Cephalosporins, and injectable antibiotics produced using advanced enzymatic technology. Beyond antibiotics, the company manufactures a wide range of therapeutic solutions for cardiovascular health, diabetes, musculoskeletal conditions, respiratory systems, and digestive health, as well as vitamins and health supplements. Their dosage forms include lyophilized injections, dispersible tablets, hard capsules, and oral suspensions.
As a key player in international trade, Imexpharm has successfully registered 28 Market Authorization Units (MAUs) in Europe, demonstrating its capability to meet global quality benchmarks. The company provides contract manufacturing and OEM services, collaborating with multinational partners such as Sandoz, Sanofi-Aventis, and Pharmacience Canada. Backed by strategic investment from South Korea's SK Group, Imexpharm continues to expand its R&D capabilities and non-antibiotic product lines to serve both domestic healthcare needs and international export markets.
Thực Phẩm Bảo Vệ Sức Khỏe
Vitamin & khoáng chất
Nhóm dùng ngoài
Diệt trừ ký sinh trùng
Tiểu đường
Tiêu hóa gan mật
Giãn mạch ngoại biên và hoạt hóa não
Kháng Histamin & Kháng dị ứng
Hệ hô hấp
Giảm đau - kháng viêm - hạ sốt
Cơ xương khớp
Mắt
Can Gio Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
1982301-500 peopleManufacturer/Trading CompanyEstablished brand
OEM manufacturer
Key market
🇻🇳 Vietnam
Description
Can Gio Pharmaceutical Joint Stock Company (Cagipharm) is a prominent Vietnamese manufacturer and trading company established in 1982. Headquartered in Ho Chi Minh City and listed on the UPCOM stock exchange, the company operates with a workforce of approximately 395 to 500 employees. It maintains a diversified business structure through subsidiaries such as Us Pharma Usa Joint Stock Company and International Hospital Joint Stock Company, reflecting its significant scale within the regional healthcare sector.
CADIGESIC Caplet 500
Giải Độc Gan
Giảm Cân
Nghệ Nano
Dưỡng Trắng Da
USgout
BỔ THẬN DƯƠNG
ĐẠI TRÀNG
TRINH NỮ HOÀNG CUNG
Alpha-tase
CADIMIN MULTI
BETACLO
